Tumour-specific bioorthogonal synthesis of proteolysis-targeting chimeras and nanoparticles boosts T cell activity
{{output}}
Redirecting immune cells or therapeutic molecules to cancer targets without harming healthy tissues remains a major challenge. Here we present a tumour-selective ligation strategy that enables in situ assembly of proximity-based therapies, including proteolysi... ...
